Indonesia is one of Southeast Asia’s fastest-growing health and wellness markets, with a consumer base that is increasingly health-conscious and a supplement industry expanding at a steady pace year over year. For foreign brands and exporters, this growth represents a genuine commercial opportunity.
But before a single bottle reaches Indonesian shelves or an online cart, there is one non-negotiable step that every international manufacturer must complete: supplement registration in Indonesia through the country’s official regulatory body, the Badan Pengawas Obat dan Makanan (BPOM).
Understanding this process early is not just a legal obligation. It is a strategic decision that shapes how smoothly, quickly, and profitably a foreign brand can enter the market.
Why Indonesia’s Supplement Market Demands Proper Registration
Indonesia’s population of more than 270 million people represents an enormous addressable market for health supplements, vitamins, herbal products, and wellness formulations.
The country’s growing middle class, increasing health awareness post-pandemic, and expanding e-commerce infrastructure have collectively created ideal conditions for supplement brands looking to expand internationally.
Yet Indonesia operates a strict pre-market approval framework for health supplements. Unlike some markets where supplements are lightly regulated or require only notification, Indonesia mandates full BPOM registration before any product can be legally imported, distributed, advertised, or sold.
This applies to all forms of supplements, including tablets, capsules, softgels, powders, liquids, and functional foods with added health benefit claims.
Brands that attempt to enter without approved registration risk product seizure at customs, significant fines, and reputational damage. Getting the process right from the start is simply the smarter path.
The Regulatory Framework: Key Regulations Foreign Brands Must Know
The legal foundation for supplement registration in Indonesia rests on several BPOM regulations and ministerial decrees. The most relevant ones for international manufacturers include:
BPOM Regulation No. 17 of 2022 governs the registration of health supplements and traditional medicines, setting out product classification, documentation requirements, safety and efficacy standards, and labeling obligations.
Government Regulation No. 86 of 2019 on food safety broadly covers the safety standards that processed food and supplement products must meet before market entry.
BPOM Regulation No. 31 of 2018 provides detailed guidelines on the registration of food products, including the scope of claims, prohibited ingredients, and labeling requirements in Bahasa Indonesia.
BPOM Regulation No. 11 of 2020 addresses good manufacturing practices (GMP) and facility compliance, which foreign manufacturers must demonstrate when submitting their registration dossier.
Incorrect product classification or non-compliant labeling claims are among the most common reasons foreign brands face delays or rejections during the evaluation process.
For an authoritative overview of Indonesian food and supplement regulations from an international perspective, the Codex Alimentarius Commission, published by the FAO and WHO, provides a useful global reference point that aligns with many of BPOM’s underlying safety principles.
Product Classification: Supplements vs Traditional Medicines
One of the first critical decisions in supplement registration in Indonesia is determining how the product will be classified. BPOM draws a clear distinction between health supplements (Suplemen Kesehatan) and traditional medicines (Obat Tradisional).
This classification determines the applicable registration pathway, documentation requirements, and permitted claims.
Health supplements are products formulated to complement daily nutritional intake. These typically include vitamins, minerals, amino acids, enzymes, and botanical concentrates in concentrated forms.
Traditional medicines, on the other hand, are based on traditional formulations, often herbal or plant-derived, with roots in local or historical medicinal practices.
This is where working with a specialist regulatory team proves its value long before the actual submission is filed.
The Supplement Registration Process
While the specifics vary based on product type, ingredient profile, and manufacturing country of origin, the general pathway for supplement registration in Indonesia follows a structured sequence.
Step 1 – Pre-submission Assessment: The product’s formulation, ingredients, and health claims are reviewed for compliance with BPOM standards. Any ingredients flagged as restricted or requiring special documentation are identified at this stage.
Step 2 – Facility Documentation: Foreign manufacturers must provide evidence of GMP compliance. BPOM may accept certificates issued by a recognized regulatory authority in the country of origin, such as the FDA (USA), TGA (Australia), or equivalent national authorities. Additional documentation may be required for higher-risk formulations.
Step 3 – Dossier Preparation: A complete registration dossier is compiled. This includes a Letter of Authorization from the manufacturer, Certificate of Free Sale from the country of origin, product composition and stability data, labeling in Bahasa Indonesia, and safety documentation tailored to BPOM’s evaluation criteria.
Step 4 – BPOM Submission and Evaluation: The dossier is submitted through BPOM’s e-registration portal. BPOM evaluates the product and may raise queries or request additional data. Response time and quality at this stage significantly affect the overall timeline.
Step 5 – Approval and Post-Market Compliance: Once approved, the product receives its BPOM registration number, which must appear on all product labels distributed in Indonesia. The approval is valid for five years, after which renewal must be completed before expiry.
A Critical Factor for Foreign Manufacturers
Foreign manufacturers without an Indonesian subsidiary or distributor cannot hold a BPOM registration number directly. That is why the license holder scheme will be so beneficial for them rather than establishing a foreign company in Indonesia.
What Is a License Holder, and Why Does It Matter?
A license holder in Indonesia is more than just a name on a registration document. Under Indonesian import regulations, the license holder also functions as the official importer of record. The local entity that is legally accountable for customs clearance, import duties, taxes, and regulatory compliance each time the product enters the country.
In practical terms, this means:
- Files and holds the BPOM registration on behalf of the foreign manufacturer
- Holds the Angka Pengenal Importir (API), the import identification number required to legally bring goods through Indonesian customs
- Bears full regulatory responsibility before BPOM, the Directorate General of Customs, and other relevant authorities
- Manages post-market obligations, including safety reporting, label updates, and renewal filings
For foreign brands, this creates a critical dependency. If the local distributor holds both the license and the import record, the foreign manufacturer effectively transfers control of its market position to a commercial partner.
Should that relationship break down, regaining control of the product registration can be a lengthy and disruptive process.
Why the License Holder Model Is the Preferred Market Entry Route
Instead of immediately establishing a PT PMA (an Indonesian foreign-owned company with substantial capital requirements), the license holder model offers foreign brands a quicker and more adaptable route to entering the market.
The advantages are substantial:
- No local company required. Brands can begin selling in Indonesia without establishing their own Indonesian entity, eliminating incorporation costs and timelines.
- Faster time to market. A licensed local entity already holds the necessary API and has established working relationships with BPOM, allowing the registration process to begin immediately.
- Market validation before full commitment. Brands can test commercial performance in the Indonesian market before deciding whether to invest in setting up their own subsidiary.
- Transition flexibility. If a brand later establishes a PT PMA, the BPOM registration held by the license holder can be transferred through a Variation Registration filing, preserving the original registration number without requiring a full resubmission.
The Risk of Using a Local Distributor as License Holder
Many foreign brands default to appointing their local distributor as the license holder, treating it as a convenience rather than a strategic decision. This approach carries meaningful long-term risk.
If the distributor is the holder of the BPOM license, they maintain legal control over the product’s registration. Should the commercial relationship cease due to factors such as a disagreement over pricing, a shift in distribution strategy, or the foreign manufacturer finding a more favorable opportunity with a rival brand, the manufacturer is not entitled to simply reclaim the registration.
Transferring the license out of a distributor’s name requires the distributor’s cooperation, which cannot always be guaranteed.
Conclusion
Indonesia’s health supplement market will not wait. Thousands of international brands are already competing for shelf space and consumer attention in this dynamic market.
The brands that secure their regulatory approvals early, with the right partner by their side, are the ones that get there first.
If your brand is ready to take the next step, or even just exploring what supplement registration in Indonesia would involve for your specific products, reach out to us today for a free initial consultation.
The right guidance at the right stage can save months of delay and high cost before you ever launch.
Frequently Asked Questions (FAQs)
Q1: Is supplement registration in Indonesia mandatory for all imported products?
Yes, all imported health supplements, vitamins, traditional medicines, and dietary supplements must obtain BPOM registration approval before they can be legally imported, marketed, or sold in Indonesia.
Products found in the market without a valid BPOM registration number are subject to seizure and penalties under Indonesian law.
Q2: How long does supplement registration in Indonesia typically take?
The timeline varies depending on product complexity, documentation completeness, and BPOM’s evaluation workload. Generally, the process ranges from six to twelve months for straightforward products. Complex formulations, unusual ingredients, or incomplete dossiers can extend this significantly. Working with a regulatory specialist helps minimize unnecessary delays.
Q3: Can a foreign manufacturer hold their own BPOM supplement registration?
No. Indonesian regulations require that the registration license be held by a legally established Indonesian entity. Foreign manufacturers must either appoint a local distributor, establish an Indonesian subsidiary (PT PMA), or engage a neutral license holder such as Product Registration Indonesia to hold the registration on their behalf.
Q4: What is the difference between a license holder and an importer of record?
In the Indonesian supplement context, these roles are closely linked. The license holder is the local entity that holds the BPOM registration and assumes regulatory responsibility for the product.
As importer of record, that same entity also holds the API (import license) and bears legal accountability for customs clearance, duties, and compliance each time goods are imported. PRI fulfills both functions as part of its License Holder Service, giving foreign brands a single, neutral point of regulatory and import accountability.
Q5: What happens to the BPOM registration if a foreign brand changes its local distributor?
If the distributor holds the BPOM license, switching distributors can create serious regulatory complications, as the registration is tied to the distributor’s legal entity. Using a neutral license holder service, like the one offered by Product Registration Indonesia, ensures that the registration remains with an independent party and can be transferred or reassigned to a new distributor without risk to the approval.
Q6: Are there any ingredients or claims that BPOM does not allow in supplement registrations?
Yes. BPOM maintains a list of restricted and prohibited ingredients for supplement products. Additionally, health claims that imply treatment, cure, or prevention of diseases are not permitted for supplements. Claims must be factual, substantiated, and stay within BPOM’s approved functional claim framework. We review ingredient profiles and claims as part of its pre-submission assessment service to identify and resolve these issues before filing.
Q7: Does BPOM audit foreign manufacturing facilities?
BPOM may request facility documentation, third-party audit reports, or additional GMP evidence for foreign manufacturing facilities, particularly for higher-risk products. In some cases, BPOM may conduct or commission direct facility inspections. PRI assists foreign manufacturers with inspection readiness and coordinates the submission of all facility-related documentation to align with BPOM’s expectations.
